Back to FLU - INFLUENZA News List

Two Contracts Awarded to Expand Domestic Vaccine Manufacturing Capacity

The two cost-reimbursable contracts totaling 2.5 million over five years are to retrofit existing domestic vaccine manufacturing facilities on a cost-sharing basis and to provide warm-base operations for manufacturing pandemic influenza vaccines. In warm-base operations, the contractor does not shut down the facility.

Source: http://www.pandemicflu.gov
 

Each year, millions of people contract influenza and flu-like infections in the United States, resulting in over 100,000 hospitalizations and approximately 20,000 deaths.